13F HOLDINGS REPORT
ACUTA CAPITAL PARTNERS, LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001104659-25-013432
Total Value
$99.4M
Positions
39
Other Managers
0
Confidential Omitted
No
Holdings (39)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | OCULAR THERAPEUTIX INC | OCUL | 1,111,071 | $9.5M | 9.55% |
| 2 | INSMED INC | INSM | 104,800 | $7.2M | 7.28% |
| 3 | TOURMALINE BIO INC | 89157D105 | 351,842 | $7.1M | 7.18% |
| 4 | CRINETICS PHARMACEUTICALS IN | CRNX | 122,900 | $6.3M | 6.32% |
| 5 | ENLIVEN THERAPEUTICS INC | ELVN | 267,368 | $6.0M | 6.05% |
| 6 | AADI BIOSCIENCES INC | WHWK | 1,849,402 | $5.8M | 5.87% |
| 7 | PRAXIS PRECISION MEDICINES I | PRAX | 67,500 | $5.2M | 5.23% |
| 8 | REVOLUTION MEDICINES INC | RVMDW | 111,700 | $4.9M | 4.92% |
| 9 | ARGENX SE | ARGX | 6,910 | $4.2M | 4.28% |
| 10 | VAXCYTE INC | PCVX | 45,000 | $3.7M | 3.71% |
| 11 | TREVI THERAPEUTICS INC | TRVI | 771,958 | $3.2M | 3.20% |
| 12 | ASCENDIS PHA-ADR | ASND | 22,976 | $3.2M | 3.18% |
| 13 | MEREO BIOPHARMA GROUP PL-ADR | MREO | 779,308 | $2.7M | 2.74% |
| 14 | BRIGHT MINDS BIOSCIENCES INC | DRUG | 69,124 | $2.5M | 2.50% |
| 15 | TERNS PHARMACEUTICALS INC | TERN | 447,500 | $2.5M | 2.49% |
| 16 | EDGEWISE THERAPEUTICS INC | EWTX | 87,658 | $2.3M | 2.35% |
| 17 | HELIX ACQUISITION CORP II | HLXC | 180,945 | $1.9M | 1.91% |
| 18 | UNICYCIVE THERAPEUTICS INC | UNCY | 2,303,000 | $1.8M | 1.84% |
| 19 | ROCKET PHARMACEUTICALS INC | RCKTW | 134,500 | $1.7M | 1.70% |
| 20 | LIQUIDIA CORPORATION | LQDA | 137,709 | $1.6M | 1.63% |
| 21 | MERSANA THERAPEUTICS INC | 59045L106 | 1,120,500 | $1.6M | 1.61% |
| 22 | TAYSHA GENE THERAPIES INC | TSHA | 884,244 | $1.5M | 1.54% |
| 23 | TECTONIC THERAPEUTIC INC | TECX | 33,008 | $1.5M | 1.53% |
| 24 | CIDARA THERAPEUTICS INC | 171757206 | 54,473 | $1.5M | 1.47% |
| 25 | NEWAMSTERDAM PHARMA CO NV | NAMSW | 50,000 | $1.3M | 1.29% |
| 26 | ZYMEWORKS INC | ZYME | 67,240 | $984,394 | 0.99% |
| 27 | ELEDON PHARMACEUTICALS INC | ELDN | 235,750 | $971,290 | 0.98% |
| 28 | VERVE THERAPEUTICS INC | 92539P101 | 160,200 | $903,528 | 0.91% |
| 29 | ULTRAGENYX PHARMACEUTICAL INC | RARE | 21,000 | $883,470 | 0.89% |
| 30 | GILEAD SCIENCES INC | GILD | 9,150 | $845,186 | 0.85% |
| 31 | ARCELLX INC | ACLX | 10,743 | $823,881 | 0.83% |
| 32 | SANGAMO THERAPEUTICS INC | SGMO | 740,000 | $754,800 | 0.76% |
| 33 | THIRD HARMONIC BIO INC | 88427A107 | 49,800 | $512,442 | 0.52% |
| 34 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 44,000 | $443,520 | 0.45% |
| 35 | FORTE BIOSCIENCES INC | FBRX | 18,139 | $411,937 | 0.41% |
| 36 | CORVUS PHARMACEUTICALS INC | CRVS | 74,307 | $397,542 | 0.40% |
| 37 | CELCUITY INC | CELC | 25,000 | $327,250 | 0.33% |
| 38 | RAPPORT THERAPEUTICS INC | RAPP | 16,400 | $290,936 | 0.29% |
| 39 | NUVATION BIO INC -CW27 | NUVB | 90,832 | $20,891 | 0.02% |